Literature DB >> 750106

The clinical evaluation of analogues. I. The overall problem.

S K Carter.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 750106     DOI: 10.1007/bf00254038

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  6 in total

1.  Cancer chemotherapy as it approaches middle age.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy.

Authors:  S K Carter; W T Soper
Journal:  Cancer Treat Rev       Date:  1974-03       Impact factor: 12.111

3.  Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.

Authors:  S M Sieber; R H Adamson
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

Review 4.  Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.

Authors:  S K Carter
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

Review 5.  Clinical trials in cancer chemotherapy.

Authors:  S K Carter
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

6.  Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.

Authors:  M A Goldsmith; M Slavik; S K Carter
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

  6 in total
  3 in total

1.  Modification of methyliminodiacetato-trans-R,R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody.

Authors:  M G Rosenblum; J L Murray; S Stuckey; R A Newman; S Chaney; A R Khokhar
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

Review 3.  m-AMSA and PALA: two new agents in cancer chemotherapy.

Authors:  M Rozencweig; D D Von Hoff; R L Cysyk; F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.